Identification of DTL as Related Biomarker and Immune Infiltration Characteristics of Nasopharyngeal Carcinoma via Comprehensive Strategies
Hehe Wang,Junge Zhang
DOI: https://doi.org/10.2147/IJGM.S352330
IF: 2.145
2022-03-02
International Journal of General Medicine
Abstract:Hehe Wang, 1 Junge Zhang 2 1 Department of Otolaryngology, Head and Neck Surgery, Ningbo First Hospital, Ningbo, Zhejiang, People's Republic of China; 2 Department of Anesthesiology, Ningbo First Hospital, Ningbo, Zhejiang, People's Republic of China Correspondence: Hehe Wang, Department of Otolaryngology Head and Neck Surgery, Ningbo First Hospital, Ningbo, Zhejiang, 315010, People's Republic of China, Email Purpose: Although considerable progress has been made in basic and clinical research on nasopharyngeal carcinoma (NPC), the biomarkers of the progression of NPC have not been fully studied and described. This study was designed to identify potential novel biomarkers for NPC using integrated analyses and explore the immune cell infiltration in this pathological process. Methods: Five GEO data sets were downloaded from gene expression omnibus database (GEO) and analysed to identify differentially expressed genes (DEGs), followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. The four algorithms were adopted for screening of novel and key biomarkers for NPC, including random forest (RF) machine learning algorithm, least absolute shrinkage and selection operator (LASSO) logistic regression, support vector machine-recursive feature elimination (SVM-RFE), and weighted gene co-expression network analysis (WGCNA). Lastly, CIBERSORT was used to assess the infiltration of immune cells in NPC, and the correlation between diagnostic markers and infiltrating immune cells was analyzed. Results: Herein, we identified 46 DEGs, and enrichment analysis results showed that DEGs and several kinds of signaling pathways might be closely associated with the occurrence and progression of NPC. DTL was recognized as NPC-related biomarker. DTL, also known as retinoic acid-regulated nuclear matrix-associated protein (RAMP), or DNA replication factor 2 (CDT2), is reported to be correlated with the cell proliferation, cell cycle arrest and cell invasion in hepatocellular carcinoma, breast cancer and gastric cancer. Immune infiltration analysis demonstrated that macrophages M0, macrophages M1 and T cells CD4 memory activated were linked to pathogenesis of NPC. Conclusion: In summary, we adopted a comprehensive strategy to screen DTL as biomarkers related to NPC and explore the critical role of immune cell infiltration in NPC. Graphical Keywords: nasopharyngeal carcinoma, NPC, biomarkers, machine learning algorithm, DTL Graphical Nasopharyngeal carcinoma (NPC) is a type of head and neck tumor with high invasion and metastasis originating from nasopharyngeal epithelial tissue. Although originating from similar cell or tissue lineages, NPC is significantly different from other epithelial head and neck tumors, characterized by early cervical lymph node metastasis and invasion of the base of the skull, with significant ethnic and geographic specificity, and the highest incidence of distant metastasis of NPC in head and neck tumors. 1–3 Unfortunately, early-stage cancers can be asymptomatic, so biomarkers such as circulating cell-free Epstein–Barr virus (EBV) DNA are used to detect NPC in populations at risk for the disease. 4 Subjects with elevated plasma biomarkers are assessed by nasopharyngeal endoscopic examination. Those with an abnormality suspicious of NPC undergo endoscopic-guided biopsy for histological confirmation of NPC, whereas those without a suspicious abnormality are considered to have had a false-positive blood test. However, small tumors hidden in the pharyngeal recess, adenoid or beneath the mucosa can be missed on endoscopic examination and the number of such tumors in populations screened for NPC is unknown. 5–8 Some studies had found that neoplastic spindle cells have features of epithelial mesenchymal transition (EMT) and cancer stem cells (CSCs), and should be considered as the more aggressive subtype in NPC, and the predictors of tumor cell dissemination and metastasis of patients. 9,10 Although considerable progress has been achieved in basic and clinical research on NPC, the biomarkers of the progression of NPC is not fully studied and described. Thus, further investigation is beneficial, especially for identification of potential biomarkers to improve survival in patients for whom the NPC is in its early-stages. With the development of sequencing technologies and microarray, we can easily screen the expression level of thousands of genes simultaneously in the human genome. 11 Comprehensive analysis of multiple datasets provides the capabilities to properly identify and assess the pathways and genes that mediate the biological processes associated wi -Abstract Truncated-
medicine, general & internal